UltraZyme - Enzymatic tools for ultrafast, sensitive and specific detection of viral infectious diseases at Point-Of-Care

  • Funded by The Research Council of Norway (RCN)
  • Total publications:0 publications

Grant number: 341642

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2023
    2025
  • Known Financial Commitments (USD)

    $506,208.61
  • Funder

    The Research Council of Norway (RCN)
  • Principal Investigator

    Atle Noralf Larsen
  • Research Location

    Norway
  • Lead Research Institution

    UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET, FAKULTET FOR NATURVITENSKAP OG TEKNOLOGI
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Viral pandemics such as COVID-19 represent a global health threat, and as we have all experienced, we need effective surveillance strategies to combat such large disease outbreaks. Identification of people carrying the virus is critical, and early detection is our best chance of preventing these outbreaks. Simple, super-fast and accurate tests that can be used at home or close to the patient are thus absolutely essential, and although antigen tests are easy to use and were indispensable during the peak of the COVID 19 pandemic, they still lacked the desired accuracy compared to hospital-based PCR tests. In the Ultrazyme project, we want to develop an enzyme tailored for use in molecular-based self-tests, but with the accuracy of PCR-based tests. Since the enzyme works well at room temperature, sophisticated equipment is not required. By succeeding in this project, UltraZyme can offer the enzymatic solution for a rapid and cost-effective test for disease identification and monitoring. A key element is that the test can be carried out without the use of trained personnel or own equipment.